The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement
Abstract
DESCRIPTION: Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility. METHODS: The USPSTF reviewed the evidence on risk assessment,genetic counseling, and genetic testing for potentially harmful BRCA mutations in asymptomatic women with a family history of breast or ovarian cancer but no personal history of cancer or known potentially harmful BRCA mutations in the family. The USPSTF also reviewed interventions aimed at reducing the risk for BRCA-related cancer in women with potentially harmful BRCA mutations, including intensive cancer screening, medications, and risk-reducing surgery. POPULATION: This recommendation applies to asymptomatic women who have not been diagnosed with BRCA-related cancer. RECOMMENDATION: The USPSTF recommends that primary care providers screen women who have family members with breast, ovarian, tubal, or peritoneal cancer with 1 of several screening tools designed to identify a family history that may be associated with an increased risk for potentially harmful mutations in breast cancer susceptibility genes (BRCA1 or BRCA2). Women with positive screening results should receive genetic counseling and, if indicated after counseling, BRCA testing. (B recommendation)The USPSTF recommends against routine genetic counseling or BRCA testing for women whose family history is not associated with an increased risk for potentially harmful mutations in the BRCA1 or BRCA2 genes. (D recommendation).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Rubin, M., & Stephen, C. D. (1993) · Cited by 3,149
Ma, J., & Jemal, A. (2013) · Breast Cancer Metastasis and Drug Resistance · doi:10.1007/978-1-4614-5647-6_1 · Cited by 1,907
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation
Kauff, N. D., Satagopan, J. M., Robson, M. E., Scheuer, L., Hensley, M., Hudis, C. A., Ellis, N. A., Boyd, J., Borgen, P. I., Barakat, R. R., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020119 · Cited by 1,251
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 934
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2
Roa, B. B., Boyd, A. A., Volcik, K., & Richards, C. S. (1996) · Nature Genetics · doi:10.1038/ng1096-185 · Cited by 770
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0076 · Cited by 646
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Eisen, A., Lubinski, J., Klijn, J., Moller, P., Lynch, H. T., Offit, K., Weber, B., Rebbeck, T., Neuhausen, S. L., Ghadirian, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.7138 · Cited by 443
Armstrong, K. (2005) · JAMA · doi:10.1001/jama.293.14.1729 · Cited by 432
Powles, T. J., Ashley, S., Tidy, A., Smith, I. E., & Dowsett, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk050 · Cited by 430
Robson, M. E., Storm, C. D., Weitzel, J., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 421
Germ-Line BRCA1 Mutations in Jewish and Non-Jewish Women with Early-Onset Breast Cancer
FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601183340302 · Cited by 385
Nelson, H. D., Huffman, L. H., Fu, R., & Harris, E. L. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00012 · Cited by 346
Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1684 · Cited by 319
Concise Handbook of Familial Cancer Susceptibility Syndromes - Second Edition
Lindor, N. M., McMaster, M. L., Lindor, C. J., & Greene, M. H. (2008) · JNCI Monographs · doi:10.1093/jncimonographs/lgn001 · Cited by 307
ACOG Practice Bulletin No. 103: Hereditary Breast and Ovarian Cancer Syndrome
(2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181a106d4 · Cited by 281
Evans, D. G. R., Eccles, D. M., Rahman, N., Young, K., Bulman, M., Amir, E., Shenton, A., Howell, A., & Lalloo, F. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.017996 · Cited by 265
Brandberg, Y., Sandelin, K., Erikson, S., Jurell, G., Liljegren, A., Lindblom, A., Lindén, A., von Wachenfeldt, A., Wickman, M., & Arver, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9568 · Cited by 265
LANCASTER, J., BETHANPOWELL, C., KAUFF, N., CASS, I., CHEN, L., LU, K., MUTCH, D., BERCHUCK, A., KARLAN, B., & HERZOG, T. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.09.031 · Cited by 251
Veronesi, U., Maisonneuve, P., Rotmensz, N., Bonanni, B., Boyle, P., Viale, G., Costa, A., Sacchini, V., Travaglini, R., D'Aiuto, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk154 · Cited by 242
BRCA in breast cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Díez, O., Rubio, I. T., & Cardoso, F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr373 · Cited by 230
The Prevalence of Common BRCA1 and BRCA2 Mutations among Ashkenazi Jews
Hartge, P., Struewing, J. P., Wacholder, S., Brody, L. C., & Tucker, M. A. (1999) · The American Journal of Human Genetics · doi:10.1086/302320 · Cited by 226
Fodor, F. H., Weston, A., Bleiweiss, I. J., McCurdy, L. D., Walsh, M. M., Tartter, P. I., Brower, S. T., & Eng, C. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301903 · Cited by 220
BRCA in breast cancer: ESMO Clinical Practice Guidelines
Balmaña, J., Diez, O., Rubio, I., & Castiglione, M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq161 · Cited by 205
Finch, A., Metcalfe, K. A., Chiang, J. K., Elit, L., McLaughlin, J., Springate, C., Demsky, R., Murphy, J., Rosen, B., & Narod, S. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.12.326 · Cited by 200
Hereditary Breast and Ovarian Cancer
Meindl, A., Ditsch, N., Kast, K., Rhiem, K., & Schmutzler, R. K. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0323 · Cited by 199
Antoniou, A. C., Hardy, R., Walker, L., Evans, D. G., Shenton, A., Eeles, R., Shanley, S., Pichert, G., Izatt, L., Rose, S., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.056556 · Cited by 194
Risk models for familial ovarian and breast cancer
Antoniou, A. C., Gayther, S. A., Stratton, J. F., Ponder, B. A. J., & Easton, D. F. (2000) · Genetic Epidemiology · Cited by 192
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
Metcalfe, K. A., Poll, A., Royer, R., Llacuachaqui, M., Tulman, A., Sun, P., & Narod, S. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0712 · Cited by 190
Nelson, H. D., Smith, M. E. B., Griffin, J. C., & Fu, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-8-201304160-00005 · Cited by 187
Gurley, E. S., Montgomery, J. M., Hossain, J., Bell, M. G. H., Azad, A. K., Islam, M. R., Molla, M. A. R., Carroll, D. S., Ksiazek, T. G., Rota, P. A., et al. (2007) · Cited by 173
Gahm, J., Wickman, M., & Brandberg, Y. (2010) · The Breast · doi:10.1016/j.breast.2010.05.003 · Cited by 146
Berliner, J. L., Fay, A. M., Cummings, S. A., Burnett, B. B., & Tillmanns, T. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9547-1 · Cited by 140
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers
Evans, D. G., Gaarenstroom, K. N., Stirling, D., Shenton, A., Mæhle, L., Dørum, A., Steel, M., Lalloo, F. I., Apold, J., Porteous, M. E., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.058248 · Cited by 137
Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy
Metcalfe, K., Esplen, M., Goel, V., & Narod, S. (2004) · Psycho-Oncology · doi:10.1002/pon.726 · Cited by 136
A molecular and clinical study of Larsen syndrome caused by mutations in FLNB
Bicknell, L. S., Farrington, C., Shafeghati, Y., Rump, P., Alanay, Y., Alembik, Y., Almadani, N., Firth, H. V., Kariminejad, M. H., Kim, C. A., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043687 · Cited by 128
Validity of Models for Predicting BRCA1 and BRCA2 Mutations
Parmigiani, G., Chen, S., Iversen, E. S., Friebel, T. M., Finkelstein, D. M., Anton-Culver, H., Ziogas, A., Weber, B. L., Eisen, A. F., Malone, K. E., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00002 · Cited by 126
A Systematic Review of the Impact of Genetic Counseling on Risk Perception Accuracy
Smerecnik, C. M. R., Mesters, I., Verweij, E., de Vries, N. K., & de Vries, H. (2009) · Journal of Genetic Counseling · doi:10.1007/s10897-008-9210-z · Cited by 125
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening
Smith, A., Moran, A., Boyd, M., Bulman, M., Shenton, A., Smith, L., Iddenden, R., Woodward, E., Lalloo, F., Maher, E., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043091 · Cited by 119
Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population
Bellcross, C. A., Lemke, A. A., Pape, L. S., Tess, A., & Meisner, L. T. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b9b04a · Cited by 118
Gilpin, C., Carson, N. L., & Hunter, A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580408.x · Cited by 115
Tamoxifen for the prevention of breast cancer
Fisher, B., Powles, T. J., & Pritchard, K. J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00269-5 · Cited by 102
Imtiaz, F., Savilahti, E., Sarnesto, A., Trabzuni, D., Al-Kahtani, K., Kagevi, I., Rashed, M. S., Meyer, B. F., & Järvelä, I. E. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.051631 · Cited by 100
Assessing BRCA Carrier Probabilities in Extended Families
Barcenas, C. H., Hosain, G. M., Arun, B. K., Zong, J., Zhou, X., Chen, J., Cortada, J. M., Mills, G. B., Tomlinson, G. E., Miller, A. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2368 · Cited by 100
Le‐Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., Litton, J. K., & Arun, B. (2011) · Cancer · doi:10.1002/cncr.25971 · Cited by 98
Finch, A., Metcalfe, K. A., Chiang, J., Elit, L., McLaughlin, J. R., Springate, C., Esplen, M. J., Demsky, R., Murphy, J., Rosen, B. P., et al. (2011) · Psycho-Oncology · doi:10.1002/pon.2041 · Cited by 93
Hoskins, K. F., Zwaagstra, A., & Ranz, M. (2006) · Cancer · doi:10.1002/cncr.22202 · Cited by 92
Patients’ Resistance to Risk Information in Genetic Counseling for BRCA1/2
Gurmankin, A. D., Domchek, S. M., Stopfer, J., Fels, C., & Armstrong, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.523 · Cited by 90
Ashton‐Prolla, P., Giacomazzi, J., Schmidt, A. V., Roth, F. L., Palmero, E. I., Kalakun, L., de Aguiar, E. S., Moreira, S. M., Batassini, É., Reyes, V. B., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-283 · Cited by 83
Kriege, M., Brekelmans, C. T. M., Boetes, C., Muller, S. H., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Rutgers, E. J. T., de Koning, H. J., et al. (2006) · Cancer · doi:10.1002/cncr.21863 · Cited by 81
Contant, C., Menke-Pluijmers, M., Seynaeve, C., Meijers-Heijboer, E. J., Klijn, J. G., Verhoog, L., Wai, R. T. J., Eggermont, A., & van Geel, A. V. (2002) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1279 · Cited by 78
Breast cancer after bilateral risk-reducing mastectomy
Skytte, A., Crüger, D. G., Gerster, M., Lænkholm, A., Lang, C., Brøndum‐Nielsen, K., Andersen, M., Sunde, L., Kølvraa, S., & Gerdes, A. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01604.x · Cited by 76
Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk
Grady, D. L., Cauley, J. A., Geiger, M. J., Kornitzer, M., Mosca, L. J., Collins, P. D., WENGER, N. K., Song, J., Mershon, J. L., Barrett-Connor, E. L., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn153 · Cited by 70
Selecting a BRCA risk assessment model for use in a familial cancer clinic
Panchal, S., Ennis, M., Cañón, S. C. M., & Bordeleau, L. J. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-116 · Cited by 69
Results of a randomized study of telephone versus in-person breast cancer risk counseling
Helmes, A. W., Culver, J. O., & Bowen, D. J. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2005.12.002 · Cited by 66
Lippman, M. E., Cummings, S. R., Disch, D. P., Mershon, J. L., Dowsett, S. A., Cauley, J. A., & Martino, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0688 · Cited by 65
Matloff, E. T., Moyer, A. E., Shannon, K. M., Niendorf, K. B., & Col, N. F. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.843 · Cited by 60
Psychological Factors Associated with Emotional Responses to Receiving Genetic Risk Information
Bennett, P. D., Wilkinson, C., Turner, J., Brain, K. E., Edwards, R. T., Griffith, G. L., France, B., & Gray, J. R. (2008) · Journal of Genetic Counseling · doi:10.1007/s10897-007-9136-x · Cited by 53
Kurian, A. W., Gong, G. D., John, E. M., Johnston, D. A., Felberg, A., West, D. W., Miron, A., Andrulis, I. L., Hopper, J. L., Knight, J. A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4440 · Cited by 49
Roshanai, A. H., Rosenquist, R., Lampic, C., & Nordin, K. (2009) · Acta Oncologica · doi:10.1080/02841860903104137 · Cited by 47
Wasteson, E., Sandelin, K., Brandberg, Y., Wickman, M., & Arver, B. W. (2010) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2010.01204.x · Cited by 38
Pieterse, A. H., Ausems, M. G. E. M., Spreeuwenberg, P. M. M., & van Dulmen, S. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.01.017 · Cited by 37
Oros, K., Ghadirian, P., Maugard, C. M., Perret, C., Paredes, Y., Mes‐Masson, A., Foulkes, W. D., Provencher, D. M., & Tonin, P. N. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00673.x · Cited by 36
Brandberg, Y., Arver, B. W., Johansson, H., Wickman, M., Sandelin, K., & Liljegren, A. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.10.010 · Cited by 36
Development of a risk assessment tool for women with a family history of breast cancer
Braithwaite, D., Sutton, S. R., Mackay, J., Stein, J., & Emery, J. D. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.06.001 · Cited by 35
Effects of a telephone counseling intervention on sisters of young women with breast cancer
Bloom, J. R., STEWART, S. L., Chang, S. M., & You, M. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.07.002 · Cited by 31
A prospective study of breast cancer risk in relatives of BRCA1/BRCA2 mutation carriers.
Rowan, E., Poll, A., & Narod, S. A. (2007) · Europe PMC (PubMed Central) · Cited by 30
Hopwood, P., Wonderling, D. E., Watson, M., Cull, A., Douglas, F., Cole, T. R. P., Eccles, D., Gray, J., Murday, V. A., Steel, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602081 · Cited by 22
Effects of counseling Ashkenazi Jewish women about breast cancer risk.
Bowen, D. J., Burke, W., Culver, J. O., Press, N. A., & Crystal, S. R. (2006) · Cultural Diversity & Ethnic Minority Psychology · doi:10.1037/1099-9809.11.4.0 · Cited by 21
Bennett, P. D., Wilkinson, C., Turner, J., et al. (2008) · Familial Cancer · doi:10.1007/s10689-008-9221-9 · Cited by 20
Kelly, K. M., Senter, L. A., Leventhal, H., Özakinci, G., & Porter, K. M. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.09.007 · Cited by 15
Brain, K. E., Parsons, E. P., Bennett, P. D., Cannings-John, R. L., & Hood, K. (2010) · Psycho-Oncology · doi:10.1002/pon.1807 · Cited by 12
Comparative Effectiveness of Medications To Reduce Risk of Primary Breast Cancer in Women
Hd, N., Ren, F., Humphrey, L. L., Meb, S., Jc, G., & Nygren, P. (2009) · Europe PMC (PubMed Central) · Cited by 8
Cited by
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens-Alvarado, R. L., Cannady, R. S., Pratt-Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.3809 · Cited by 1,071
Runowicz, C. D., Leach, C. R., Henry, N. L., Henry, K. S., Mackey, H. T., Cowens‐Alvarado, R. L., Cannady, R. S., Pratt‐Chapman, M. L., Edge, S. B., Jacobs, L. A., et al. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21319 · Cited by 728
Breast Cancer Epidemiology, Prevention, and Screening
Winters, S., Martin, C., Murphy, D., & Shokar, N. K. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.07.002 · Cited by 667
Velleca, A., Shullo, M. A., Dhital, K., Azeka, E., Colvin, M., DePasquale, E., Farrero, M., García-Guereta, L., Jamero, G., Khush, K., et al. (2023) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.015 · Cited by 645
US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., et al. (2019) · JAMA · doi:10.1001/jama.2019.10987 · Cited by 467
Metadata
- Authors
- Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2014-02-18
- Volume
- 160
- Issue
- 4
- Pages
- 271-281
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2100787726
- Cited by
- 409
- References
- 80
- FWCI
- 24.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.